Advisory Services Network’s Arcturus Therapeutics ARCT Stock Holding History

Advisory Services Network’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9	Closed	-$166	–	1927
2025 Q3	$166	Buy	+9	New	+$145	﹤0.01%	4250
2024 Q1	–	Sell	-6	Closed	-$189	–	1564
2023 Q4	$189	Buy	+6	New	+$143	﹤0.01%	3736
2021 Q3	–	Sell	-100	Closed	-$3K	–	1492
2021 Q2	$3K	Buy	+100	New	+$3.38K	﹤0.01%	3191
2021 Q1	–	Sell	-100	Closed	-$4K	–	1377
2020 Q4	$4K	Hold	100	–	–	﹤0.01%	2764
2020 Q3	$4K	Buy	+100	New	+$4.96K	﹤0.01%	2823

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Advisory Services Network's ARCT Position: Q4 2025 in Review

Advisory Services Network sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 9 shares — an estimated $166 sold.

Advisory Services Network first reported a position in ARCT in Q3 2020 and held it in 5 quarters. The position peaked at $4K in Q4 2020. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

Advisory Services Network reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
Advisory Services Network sold 9 Arcturus Therapeutics shares in Q4 2025, an estimated $166.
Advisory Services Network first reported a position in Arcturus Therapeutics in Q3 2020 and held it in 5 quarters.
Advisory Services Network's Arcturus Therapeutics position peaked at $4K in Q4 2020.
120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Advisory Services Network's 13F filing for Q4 2025, filed 17 Feb 2026.